Antagonists of the serotonin receptor 5A target human breast tumor initiating cells | BMC Cancer | Full Text

Antagonists of the serotonin receptor 5A target human breast tumor initiating cells | BMC Cancer | Full Text

Antagonists of the serotonin receptor 5A target human breast tumor initiating cells

Breast tumor initiating cells (BTIC) are stem-like cells that initiate and sustain tumor growth, and drive disease recurrence. Identifying therapies targeting BTIC has been hindered due primarily to their scar...

Authors:William D. Gwynne, Mirza S. Shakeel, Adele Girgis-Gabardo, Kwang H. Kim, Emily Ford, Anna Dvorkin-Gheva, Craig Aarts, Methvin Isaac, Rima Al-awar and John A. Hassell

Citation:BMC Cancer 2020 20:724

Content type:Research article

 

Published on: 5 August 2020

• ViewFull Text
 
• ViewPDF